Latest Ventricular fibrillation Stories

Researchers in Spain have reported a possible link between the deaths of young men and incarceration.On Tuesday, Manuel Martinez Selles of Madrid's Hospital Gregorio Maranon announced his findings at the annual meeting of the European Society of Cardiology. Through his investigation of 60 unexplained deaths of persons who had been arrested in Spain, Selles found that death occurred at the point of arrest in one third of the cases. The remaining two thirds of deaths occurred within 24 hours of...

By Freeman, Kimberly Hendey, Gregory W; Shalit, Marc; Stroh, Geoff ABSTRACT Study Objective. To compare the outcomes of out-of hospital cardiac arrest (OHCA) victims treated with monophasic truncated exponential (MTE) versus biphasic truncated exponential (BTE) defibrillation in an urban EMS system. Methods. We conducted a retrospective review of electronic prehospital and hospital records for victims of OHCA between August 2000 and July 2004, including two years before and after...

St. Jude Medical, Inc. (NYSE:STJ) today announced regulatory approval, in addition to reimbursement approval, from the Japanese Ministry of Health, Labour and Welfare (MHLW), for the Durata(TM) defibrillation lead, the company's next-generation high-voltage lead. The Durata lead incorporates a soft silicone tip with a larger surface area and a slightly curved right ventricle (RV) shock coil intended to enhance ease of use and handling for physicians implanting an ICD (implantable...

SCHAUMBURG, Ill., July 25 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced that it has launched amiodarone HCl injection, USP, a class III antiarrhythmic indicated for the treatment and prophylaxis of frequently recurring ventricular fibrillation and hemodynamically unstable ventricular tachycardia -- a potentially life-threatening irregular heart beat. Sagent's amiodarone HCl injection will be available immediately in 150 mg/3...

Harbinger Medical Inc.(TM) of Minneapolis, Minnesota USA today announced the results of a study presented at the 2008 Cardiostim meeting in Nice. Four abstracts, including two poster workshops by the study's primary investigator Dr. Peter Brady, FRCP, Mayo Clinic, Rochester MN, showed that a Wedensky Modulation Index identified more than 80 percent of all life-threatening arrhythmic events that occurred in the study population. The Harbinger ICD Patient (HIP) study culminated years of...

Vicor Technologies, Inc. (OTCBB: VCRT), reviewed strategies and developments to (i) commercialize its patented device, the PD2i Cardiac Analyzer, for risk stratification of patients for Sudden Cardiac Death (SCD); (ii) its collaboration with the U.S. Army to assess severity of injury, and probability of survival, for critically injured combat casualties and critically ill civilian patients and (iii) other milestones at its Annual Meeting of Stockholders today in Boca Raton, Florida. Vicor...

Some medical devices such as implantable cardiac defibrillators and pacemakers are now equipped with wireless technology, allowing for remote device checks and freeing patients from repeated doctor visits. But this convenience may come with unanticipated risks. A team of researchers from three leading universities has demonstrated that patients' private medical information could be extracted and their devices reprogrammed without the patients' authorization or knowledge.There has never been a...

Researchers in Arizona reported that three times as many people survived a cardiac arrest when a new method of resuscitation, which involves a series of 200 chest compressions followed by defibrillator shock, was implemented.   "Cardiac arrest is incredibly common and survival is poor," said Dr. Bentley Bobrow, medical director for emergency services for the state of Arizona and a researcher at the Mayo Clinic in Scottsdale.   The new resuscitation method, which is not...

By Amanda Beck WASHINGTON (Reuters) - The number of people with a dangerous heart arrhythmia is higher than previously estimated and increasing, researchers reported on Monday. In a study of Minnesota residents, the incidence of atrial fibrillation rose more than 12 percent between 1980 and 2000, the researchers said. At that rate, the number of U.S. residents with the rhythm will rise to 16 million by 2050 -- nearly three times previous estimates, they added. "This is a major problem...

By Amy NortonNEW YORK -- Chest protectors used in baseball and other sports are unlikely to prevent children from suffering a rare but catastrophic injury to the heart, new research suggests.In lab tests of 12 chest protectors on the market, researchers found no evidence that the gear would prevent a child from going into cardiac arrest after a blow to the chest from a hard ball or puck.An estimated 10 to 20 people die each year in such incidents, most often in baseball, but also in...